AbbVie Inc. 8-K Report: Key Insights on Stocks & Senior Notes (Jan 9, 2025)

Here are the key insights extracted from the provided section of the financial report:

1. Company Identification:

• Entity Name: AbbVie Inc.
• CIK Number: 0001551152
• IRS Number: 32-0375147
• Address: 1 North Waukegan Road, North Chicago, IL 60064-6400
• Phone: 847-932-7900

2. Report Type:

• Filing Type: 8-K
• Filing Date: January 9, 2025

3. Stock Information:

• Common Stock: $0.01 Par Value
• Ticker Symbols: ABBV (NYSE), ABBV27 (0.750% Senior Notes due 2027), ABBV28 (2.125% Senior Notes due 2028), ABBV28B (2.625% Senior Notes due 2028), ABBV29 (2.125% Senior Notes due 2029), ABBV31 (1.250% Senior Notes due 2031).

4. Exchange Listings:

• Common Stock and various Senior Notes are listed on NYSE (New York Stock Exchange).
• Additional listing on XCHI (likely referring to the Toronto Stock Exchange).

5. Debt Instruments:

• The report includes various classes of Senior Notes with the following due dates and interest rates:
• • 0.750% Senior Notes due 2027
  • 2.125% Senior Notes due 2028
  • 2.625% Senior Notes due 2028
  • 2.125% Senior Notes due 2029
  • 1.250% Senior Notes due 2031

6. Reporting Context:

• The reporting period for all identified financial instruments and stock is January 9, 2025.

7. Regulatory Compliance:

• The filing adheres to XBRL (eXtensible Business Reporting Language) standards, utilizing various namespaces for compliance with SEC reporting requirements.

This information provides an overview of AbbVie Inc.’s current financial reporting status, stock structure, and outstanding debt instruments as of the given date. This is critical for investors, analysts, and stakeholders assessing the company’s financial health and obligations.